Bigul

After Trump win, bet on pharma: Sharekhan

We like Glenmark Pharma and Aurobindo because these two companies have extremely high approval rates
10-11-2016
Bigul

Outcome of Board Meeting - Resignation of Company Secretary & Compliance Officer

Glenmark Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on October 27, 2016 noted and approved the resignation of Mr. Sanjay Kumar Chowdhary, Company Secretary & Compliance Officer with effect from October 31, 2016.
28-10-2016
Bigul

2 Diwali stock picks from Prabhudas Lilladher

"SBI and Glenmark are the two stocks we are recommending to our clients."
28-10-2016

Glenmark's Q2 profit grows at 3.5% despite 16% rise in revenue

Glenmark's net profit rose to Rs223.6 crore for the three months ended 30 September from Rs216.1 crore a year ago
27-10-2016
Bigul

Announces Q2 results (Standalone & Consolidated), Limited Review Report (Standalone & Consolidated), Results Press Release & Management Discussion & Analysis for the Quarter ended September 30, 2016

Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended September 30, 2016The Unaudited Standalone results for the Quarter ended September 30, 2016 The Company has posted a net profit of Rs. 5558.28 million for the quarter ended September 30, 2016 as compared to Rs. 3721.74 million for the quarter ended September 30, 2015. Total Income has increased from Rs. 16276.29 million for the quarter ended September...
27-10-2016
Bigul

Glenmark gets USFDA nod for anti-fungal ointment

Glenmark Pharmaceuticals today said it has received final approval from the US health regulator for antifungal ointment nystatin and triamcinolone acetonide. Glenmark Pharmaceuticals USA has...
25-10-2016
Bigul

Glenmark Pharmaceuticals receives ANDA approval for Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1 mg/g

Glenmark Pharmaceuticals Ltd has submitted to BSE a copy of Press Release dated October 25, 2016 titled ''Glenmark Pharmaceuticals receives ANDA approval for Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1 mg/g".
25-10-2016
Bigul

Details of Earnings Call

Glenmark Pharmaceuticals Ltd has informed BSE about the details of Earnings Call slated for October 28, 2016, 8:30 a.m. - 9:30 a.m. (IST).
21-10-2016
Bigul

Q2 results on Oct 27, 2016

Glenmark Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors will be held on October 27, 2016, to consider and approve the Company's Unaudited Financial Statements for Second Quarter/Half Year ended September 30, 2016 (Q2).Further, as per the "Code of Conduct for Prevention of Insider Trading" of the Company, the trading window closed for Directors and other designated employees of the Company on September 29, 2016...
17-10-2016
Bigul

Glenmark appoints Dr. Kurt Stoeckli as President and Chief Scientific Officer

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated October 13, 2016 titled "Glenmark appoints Dr. Kurt Stoeckli as President and Chief Scientific Officer".
13-10-2016
Next Page
Close

Let's Open Free Demat Account